Biocartis Group NV (BCART) - Total Liabilities

Latest as of June 2023: €166.97 Million EUR ≈ $195.20 Million USD

Based on the latest financial reports, Biocartis Group NV (BCART) has total liabilities worth €166.97 Million EUR (≈ $195.20 Million USD) as of June 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Biocartis Group NV to see how much of total assets are deployed in long-term investments.

Biocartis Group NV - Total Liabilities Trend (2012–2022)

This chart illustrates how Biocartis Group NV's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BCART current and non-current assets.

Biocartis Group NV Competitors by Total Liabilities

The table below lists competitors of Biocartis Group NV ranked by their total liabilities.

Company	Country	Total Liabilities
Inderes Oyj HE:INDERES	Finland	€7.06 Million
SAF Tehnika A/S F:VTZ	Germany	€12.41 Million
Ribbon Acquisition Corp Class A Ordinary Shares NASDAQ:RIBB	USA	$3.03 Million
ELUON Corporation KQ:065440	Korea	₩26.80 Billion
SunCar Technology Group Inc. NASDAQ:SDA	USA	$162.51 Million
Nova EYE Medical Ltd AU:EYE	Australia	AU$7.31 Million
Scienjoy Holding Corp NASDAQ:SJ	USA	$172.60 Million
Optrontec Inc KQ:082210	Korea	₩210.59 Billion

Liability Composition Analysis (2012–2022)

This chart breaks down Biocartis Group NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Biocartis Group NV net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-3.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biocartis Group NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biocartis Group NV (2012–2022)

The table below shows the annual total liabilities of Biocartis Group NV from 2012 to 2022.

Year	Total Liabilities	Change
2022-12-31	€144.56 Million ≈ $169.01 Million	-18.04%
2021-12-31	€176.38 Million ≈ $206.20 Million	+1.55%
2020-12-31	€173.69 Million ≈ $203.07 Million	-5.52%
2019-12-31	€183.84 Million ≈ $214.93 Million	+253.32%
2018-12-31	€52.03 Million ≈ $60.83 Million	+6.30%
2017-12-31	€48.95 Million ≈ $57.23 Million	+10.21%
2016-12-31	€44.42 Million ≈ $51.93 Million	+32.74%
2015-12-31	€33.46 Million ≈ $39.12 Million	+2.23%
2014-12-31	€32.73 Million ≈ $38.27 Million	+16.11%
2013-12-31	€28.19 Million ≈ $32.96 Million	-4.08%
2012-12-31	€29.39 Million ≈ $34.36 Million	--

About Biocartis Group NV

BR:BCART Belgium Diagnostics & Research

Market Cap

$31.84 Million

€27.24 Million EUR

Market Cap Rank

#24187 Global

#96 in Belgium

Share Price

€0.29

Change (1 day)

+0.00%

52-Week Range

€0.29 - €0.29

All Time High

€12.88